Milliman Healthcare Inflation Plus ETF (MHIP) Sharpe Ratio

Sharpe ratio is not yet available for MHIP. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar ETFs

The table compares Milliman Healthcare Inflation Plus ETF's Sharpe Ratio with other ETFs in the Health & Biotech Equities category across multiple time periods, showing how MHIP's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jul 8, 2026.

Symbol	Name	1Y Sharpe Ratio
BBC	Virtus LifeSci Biotech Clinical Trials ETF	4.88
SBIO	ALPS Medical Breakthroughs ETF	4.05
XBI	SPDR S&P Biotech ETF	3.66
LFSC	F/m Emerald Life Sciences Innovation ETF	3.36
IHE	iShares U.S. Pharmaceuticals ETF	3.34
IBRN	iShares Neuroscience and Healthcare ETF	3.25
XPH	SPDR S&P Pharmaceuticals ETF	3.21
PJP	Invesco Dynamic Pharmaceuticals ETF	3.17
BBP	Virtus LifeSci Biotech Products ETF	3.11
FTXH	First Trust Nasdaq Pharmaceuticals ETF	3.09
MHIP	Milliman Healthcare Inflation Plus ETF	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows MHIP's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when MHIP consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does MHIP fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio